ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,449Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1844

$1.1M Total Retail Price of All Prescriptions

Rank: 33 out of 1844

524 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 17,849 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 684 673 1 1
LISINOPRIL 646 630 2 4
FUROSEMIDE 542 542 3 7
OMEPRAZOLE 509 490 4 5
AMLODIPINE BESYLATE 468 455 5 6
POTASSIUM CHLORIDE 452 452 6 16
CRESTOR 396 387 7 30
SIMVASTATIN 380 348 8 3
HYDROCODONE-ACETAMINOPHEN 373 355 S3 9 2
PRAVASTATIN SODIUM 371 367 10 10
DONEPEZIL HCL 317 304 11 26
METFORMIN HCL ER 313 296 12 46
METOPROLOL SUCCINATE 311 296 13 14
SYNTHROID 303 303 14 55
WARFARIN SODIUM 301 291 15 13
METOPROLOL TARTRATE 286 284 16 11
ATORVASTATIN CALCIUM 271 266 17 12
COUMADIN 239 239 18 175
CARVEDILOL 237 228 19 22
SERTRALINE HCL 233 217 20 21
DIOVAN 229 229 21 58
HYDROCHLOROTHIAZIDE 212 205 22 9
CITALOPRAM HBR 194 194 23 19
POLYETHYLENE GLYCOL 3350 186 175 24 39
PANTOPRAZOLE SODIUM 183 182 25 32
TAMSULOSIN HCL 171 171 26 27
ADVAIR DISKUS 164 155 27 51
ISOSORBIDE MONONITRATE ER 157 157 28 59
ZOLPIDEM TARTRATE 157 129 28 23
NAMENDA 151 151 30 33
ATENOLOL 143 143 31 17
GABAPENTIN 140 140 32 15
NEXIUM 137 137 33 31
CARBIDOPA-LEVODOPA 135 126 34 86
SINGULAIR 134 127 35 102
ESCITALOPRAM OXALATE 130 128 36 52
FLUTICASONE PROPIONATE 129 120 37 50
LOSARTAN POTASSIUM 129 129 37 24
CLOPIDOGREL 128 126 39 34
PAROXETINE HCL 120 103 40 68
GLIPIZIDE ER 120 106 40 79
LEVOTHROID 118 96 42 263
TRAMADOL HCL 111 101 43 18
RANITIDINE HCL 109 106 44 38
MIRTAZAPINE 104 104 45 49
BENICAR 104 104 45 218
METFORMIN HCL 98 97 47 8
BUMETANIDE 96 96 48 121
LANTUS 96 96 48 42
DIGOXIN 93 82 50 67
CELEBREX 93 93 50 91
NYSTOP 90 88 52 185
CIPROFLOXACIN HCL 89 89 53 62
ALLOPURINOL 87 87 54 29
NIASPAN 86 86 55 162
TORSEMIDE 85 85 56 118
EXELON 85 85 56 112
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 58 47
FLUOXETINE HCL 79 79 59 41
IPRATROPIUM BROMIDE 78 78 60 198
BYSTOLIC 77 77 61 106
JANUVIA 77 62 61 77
SPIRONOLACTONE 74 74 63 60
DILTIAZEM 24HR CD 73 73 64 132
EVISTA 71 66 65 95
PEN NEEDLE 71 71 65 135
OXYBUTYNIN CHLORIDE 70 62 67 103
LANTUS SOLOSTAR 70 70 67 97
IRBESARTAN 69 69 69 399
ROPINIROLE HCL 69 69 69 76
CEPHALEXIN 69 69 69 56
FINASTERIDE 66 57 72 137
PLAVIX 65 65 73 61
PROPRANOLOL HCL 62 62 74 129
MONTELUKAST SODIUM 60 56 75 195
NITROGLYCERIN PATCH 60 60 75 173
VERAPAMIL ER 60 60 75 98
MELOXICAM 59 52 78 28
RISPERIDONE 56 56 79 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 54 79 73
CLONIDINE HCL 52 52 81 64
CLOZAPINE 52 52 81 186
PREDNISONE 51 49 83 40
AZITHROMYCIN 51 49 83 37
NYSTATIN 50 50 85 85
LEXAPRO 50 47 85 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.